close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

JNJ

227.04

-0.24%↓

ABT

92.69

+1.62%↑

MDT

83.77

+0.47%↑

A

116.8

+1.2%↑

VEEV

161.03

+0.12%↑

JNJ

227.04

-0.24%↓

ABT

92.69

+1.62%↑

MDT

83.77

+0.47%↑

A

116.8

+1.2%↑

VEEV

161.03

+0.12%↑

JNJ

227.04

-0.24%↓

ABT

92.69

+1.62%↑

MDT

83.77

+0.47%↑

A

116.8

+1.2%↑

VEEV

161.03

+0.12%↑

JNJ

227.04

-0.24%↓

ABT

92.69

+1.62%↑

MDT

83.77

+0.47%↑

A

116.8

+1.2%↑

VEEV

161.03

+0.12%↑

JNJ

227.04

-0.24%↓

ABT

92.69

+1.62%↑

MDT

83.77

+0.47%↑

A

116.8

+1.2%↑

VEEV

161.03

+0.12%↑

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

8.99 4.29

Strong Buy

Prijsupdate 27 apr 2026, 14:10 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.62

Max

9.12

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+73.21% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

44M

202M

Vorige openingsprijs

4.7

Vorige sluitingsprijs

8.99

Nieuwssentiment

By Acuity

50%

50%

141 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

DJ

Lezen

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank -2-

DJ

Lezen

24 apr 2026, 19:19 UTC

Acquisities, Fusies, Overnames

Intertek Group Rejects EQT's Revised Offer

DJ

Lezen

26 apr 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After U.S. Tech Gains -- Market Talk

DJ

Lezen

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

DJ

Lezen

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

DJ

Lezen

26 apr 2026, 23:36 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Falls Amid Dollar's Strength -- Market Talk

DJ

Lezen

26 apr 2026, 23:33 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

DJ

Lezen

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

DJ

Lezen

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

DJ

Lezen

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

DJ

Lezen

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

DJ

Lezen

24 apr 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Scoring the Cook Era -- Barrons.com

DJ

Lezen

24 apr 2026, 20:51 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

DJ

Lezen

24 apr 2026, 20:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

DJ

Lezen

24 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

24 apr 2026, 20:39 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

DJ

Lezen

24 apr 2026, 20:09 UTC

Winsten

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

DJ

Lezen

24 apr 2026, 19:48 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

DJ

Lezen

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

DJ

Lezen

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

DJ

Lezen

24 apr 2026, 19:22 UTC

Winsten

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

DJ

Lezen

24 apr 2026, 19:06 UTC

Winsten

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

DJ

Lezen

24 apr 2026, 19:05 UTC

Marktinformatie

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

DJ

Lezen

24 apr 2026, 18:30 UTC

Acquisities, Fusies, Overnames

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

DJ

Lezen

24 apr 2026, 18:28 UTC

Acquisities, Fusies, Overnames

Intertek Rejects Revised EQT Offer

DJ

Lezen

24 apr 2026, 18:12 UTC

Marktinformatie

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

DJ

Lezen

24 apr 2026, 18:06 UTC

Marktinformatie

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

DJ

Lezen

24 apr 2026, 17:42 UTC

Winsten

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

DJ

Lezen

24 apr 2026, 17:28 UTC

Winsten

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

73.21% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15 USD  73.21%

Hoogste 28 USD

Laagste 8 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

141 / 348 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

227.04

↓-0.24%

ABT

Abbott Laboratories

92.69

↑ +1.62%

MDT

Medtronic PLC

83.77

↑ +0.47%

A

Agilent Technologies Inc

116.8

↑ +1.2%

VEEV

Veeva Systems Inc

161.03

↑ +0.12%
help-icon Live chat